Medical ventilators, also known as mechanical ventilation, can be further divided into two types: Non-Invasive Ventilation (NIV) and Invasive Mechanical Ventilation (IMV), namely non-invasive ventilators and invasive ventilators. Non-invasive ventilators, also called positive pressure ventilation devices, provide continuous positive airflow to the user in a non-invasive manner through the nose or mouth. They are used for controlling or assisting the user's breathing in a non-traumatic way. Non-invasive ventilators are primarily used in intensive care units, general wards, and homes to treat patients with mild to moderate respiratory failure. Invasive ventilators are generally used in intensive care units to treat patients with severe respiratory failure.

          Since the beginning of the 21st century, China's healthcare industry has gradually developed, leading to the growth of the ventilator market. Non-invasive ventilator therapy has become a crucial non-pharmacological treatment for patients with Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA), and is often the preferred and initial treatment method. Particularly, driven by the global pandemic environment, the foreign trade exports of many medical devices, including ventilators, have experienced rapid growth.

          According to customs data, the export of non-invasive ventilators (HS: 90192020) reached 162,058,665 units in 2022, but experienced an overall decline of 2.3% in 2023, reducing by 3,725,654 units. In contrast, the export quantity of invasive ventilators in 2023 was 7,108,592 units, showing a 35% decrease compared to 2022, with a reduction of 3,837,549 units.

         According to customs data in 2023, the foreign trade market for Chinese ventilators can be analyzed from various perspectives. Primarily, in terms of export quantity, the main markets are distributed in countries such as Singapore, Australia, the United States, and Costa Rica. In contrast, looking at export value, the major markets include the United States, Singapore, Australia, Brazil, and India. However, examining the annual market average price, the market tends to concentrate in regions such as Africa, including markets like Djibouti, Lesotho, Ethiopia, Chad, among others. In 2023, the markets with relatively high activity are still concentrated in the United States, Germany, India, and Australia.

         With the continuous advancement of technology, ventilator technology will become more advanced, efficient, intelligent, and convenient. Simultaneously, remote monitoring of ventilator data will emerge as a significant trend. Medical professionals will be able to monitor patients' respiratory conditions in real-time through cloud services, allowing for the adjustment of treatment plans as needed. In the future, there will be a greater emphasis on personalized treatment approaches in the development of ventilator technology.

         It should be noted that the positions of these markets may change over time with shifts in international circumstances. To obtain the latest and accurate information, it is recommended to refer to relevant trade statistics.

          As the first data company in China, Guomao Tong can provide accurate analysis of import and export market distribution for over 80 countries from 2010 to the present. We offer detailed transaction information for import and export enterprises, including specific quantity and price analyses, supply cycles, and more. Our reliable data serves as a solid foundation for major foreign trade enterprises and industry consulting firms.

(This article is an original creation of Guomao Tong. Please indicate the source if reprinted.)